BridgeBio Oncology Therapeutics (BBOT) Short-term Investments (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Short-term Investments of $199.6 million for Q1 2026, up 285.56% sequentially from $51.8 million in Q4 2025.
BridgeBio Oncology Therapeutics (BBOT) Short-term Investments (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Short-term Investments for 3 years, with the latest figure at $199.6 million in Q1 2026.
- Quarterly Short-term Investments changed N/A year-over-year to $199.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.6 million (changed N/A YoY) and the FY2025 annual result came in at $51.8 million, down 58.51% from the prior year.
- Short-term Investments advanced to $199.6 million in Q1 2026 per BBOT's latest filing, from $51.8 million in the prior quarter.
- Over five years, Short-term Investments peaked at $199.6 million in Q1 2026 and troughed at $51.8 million in Q4 2025.
- A 3-year average of $108.9 million and a median of $92.2 million in 2024 frame the typical range for Short-term Investments.
- The widest YoY moves for Short-term Investments: up 58.51% in 2025, down 58.51% in 2025.
- Over 3 years, Short-term Investments stood at $124.8 million in 2024, then sank by 58.51% to $51.8 million in 2025, then soared by 285.56% to $199.6 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $199.6 million, $51.8 million, and $59.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171.65 Mn |
| Mar 31, 2026 | 199.62 Mn |
| Dec 31, 2025 | 51.77 Mn |
| Sep 30, 2025 | 59.54 Mn |
| Dec 31, 2024 | 124.78 Mn |